Systematic Review Article

黄酮类化合物对胰岛素样生长因子和胰岛素样生长因子结合蛋白影响及乳腺癌发病率的系统评价和荟萃分析

卷 30, 期 14, 2023

发表于: 21 September, 2022

页: [1657 - 1666] 页: 10

弟呕挨: 10.2174/0929867329666220801164740

价格: $65

conference banner
摘要

背景:胰岛素样生长因子 (IGF-1) 与绝经期妇女的乳腺癌有关。在常见的饮食方案中发现的天然生物分子,如类黄酮,在抑制和治疗癌症方面发挥着关键作用。体外/体内研究表明,除了增加胰岛素样生长因子结合蛋白 (IGFBP)-3 外,涉及类黄酮的治疗还能降低 IGF-1 水平,从而降低患乳腺癌的风险。然而,临床研究并没有在这方面显示出确凿的结果,因为它们是相互矛盾的。 目的:本研究的目的是发现类黄酮对IGF-1和IGFBP-3以及乳腺癌发病率的影响。 方法:本系统评价使用 PubMed、Scopus、ISI Web of Science 和 EMBASE 数据库进行,以收集有关类黄酮的临床应用及其对乳腺癌影响的结果。剔除重复文章后,在专题交流中审查剩余文章的标题和摘要,并根据纳入标准选择相关临床文章进行研究。从每篇文章中提取数据,然后通过Comprehensive Meta-Analysis进行统计分析。 结果:结果表明,类黄酮对IGF1和IGFBP-3变化的影响无统计学意义。跨研究未检测到显着的异质性。汇总效应大小还表明平均变化在统计学上不显着。跨研究未检测到显着的异质性。没有证据表明 IGF1 和 IGFBP-3 存在发表偏倚。 结论:这项荟萃分析研究表明,类黄酮补充剂对 IGF-1 和 IGFBP-3 没有显着影响,高豆类饮食对 IGF 系统成分有有益影响,这可能对乳腺癌有用。

关键词: 类黄酮,胰岛素样生长因子,胰岛素样生长因子结合蛋白,乳腺癌,IGF1,IGFBP-3。

[1]
Siegel, R.L.; Miller, K.D.; Fuchs, H.E.; Jemal, A. Cancer statistics, 2021. CA Cancer J. Clin., 2021, 71(1), 7-33.
[http://dx.doi.org/10.3322/caac.21654] [PMID: 33433946]
[2]
Panjehpour, M.; Taher, M.A.; Bayesteh, M. The growth inhibitory effects of cadmium and copper on the MDA-MB468 human breast cancer cells. J. Res. Med. Sci., 2010, 15(5), 279-286.
[PMID: 21526096]
[3]
Zhou, H.; Zou, P.; Chen, Z.C.; You, Y. A novel vicious cycle cascade in tumor chemotherapy. Med. Hypotheses, 2007, 69(6), 1230-1233.
[http://dx.doi.org/10.1016/j.mehy.2007.03.038] [PMID: 17555885]
[4]
Gotwals, P.; Cameron, S.; Cipolletta, D.; Cremasco, V.; Crystal, A.; Hewes, B.; Mueller, B.; Quaratino, S.; Sabatos-Peyton, C.; Petruzzelli, L.; Engelman, J.A.; Dranoff, G. Prospects for combining targeted and conventional cancer therapy with immunotherapy. Nat. Rev. Cancer, 2017, 17(5), 286-301.
[http://dx.doi.org/10.1038/nrc.2017.17] [PMID: 28338065]
[5]
Birt, D.F.; Hendrich, S.; Wang, W. Dietary agents in cancer prevention: Flavonoids and isoflavonoids. Pharmacol. Ther., 2001, 90(2-3), 157-177.
[http://dx.doi.org/10.1016/S0163-7258(01)00137-1] [PMID: 11578656]
[6]
Ramos, S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J. Nutr. Biochem., 2007, 18(7), 427-442.
[http://dx.doi.org/10.1016/j.jnutbio.2006.11.004] [PMID: 17321735]
[7]
Ramos, S. Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways. Mol. Nutr. Food Res., 2008, 52(5), 507-526.
[http://dx.doi.org/10.1002/mnfr.200700326] [PMID: 18435439]
[8]
Mourouti, N.; Panagiotakos, D.B. Soy food consumption and breast cancer. Maturitas, 2013, 76(2), 118-122.
[http://dx.doi.org/10.1016/j.maturitas.2013.07.006] [PMID: 23916376]
[9]
Gullett, N.P.; Ruhul Amin, A.R.; Bayraktar, S.; Pezzuto, J.M.; Shin, D.M.; Khuri, F.R.; Aggarwal, B.B.; Surh, Y.J.; Kucuk, O. Cancer prevention with natural compounds. Semin. Oncol., 2010, 37(3), 258-281.
[http://dx.doi.org/10.1053/j.seminoncol.2010.06.014] [PMID: 20709209]
[10]
Yu, H.; Rohan, T. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst., 2000, 92(18), 1472-1489.
[http://dx.doi.org/10.1093/jnci/92.18.1472] [PMID: 10995803]
[11]
Baglietto, L.; English, D.R.; Hopper, J.L.; Morris, H.A.; Tilley, W.D.; Giles, G.G. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer. Cancer Epidemiol. Biomarkers Prev., 2007, 16(4), 763-768.
[http://dx.doi.org/10.1158/1055-9965.EPI-06-0960] [PMID: 17416768]
[12]
Maki, R.G. Small is beautiful: Insulin-like growth factors and their role in growth, development, and cancer. J. Clin. Oncol., 2010, 28(33), 4985-4995.
[http://dx.doi.org/10.1200/JCO.2009.27.5040] [PMID: 20975071]
[13]
Fletcher, O.; Gibson, L.; Johnson, N.; Altmann, D.R.; Holly, J.M.; Ashworth, A.; Peto, J.; Silva, Idos.S. Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: A systematic review. Cancer Epidemiol. Biomarkers Prev., 2005, 14(1), 2-19.
[PMID: 15668470]
[14]
Pfeilschifter, J.; Scheidt-Nave, C.; Leidig-Bruckner, G.; Woitge, H.W.; Blum, W.F.; Wüster, C.; Haack, D.; Ziegler, R. Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women. J. Clin. Endocrinol. Metab., 1996, 81(7), 2534-2540.
[PMID: 8675573]
[15]
Dar, A.A.; Majid, S.; Nosrati, M.; de Semir, D.; Federman, S.; Kashani-Sabet, M. Functional modulation of IGF-binding protein-3 expression in melanoma. J. Invest. Dermatol., 2010, 130(8), 2071-2079.
[http://dx.doi.org/10.1038/jid.2010.70] [PMID: 20357812]
[16]
Koyama, S.; Cobb, L.J.; Mehta, H.H.; Seeram, N.P.; Heber, D.; Pantuck, A.J.; Cohen, P. Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF-IGFBP axis. Growth Horm. IGF Res., 2010, 20(1), 55-62.
[http://dx.doi.org/10.1016/j.ghir.2009.09.003] [PMID: 19853487]
[17]
Vijayababu, M.R.; Arunkumar, A.; Kanagaraj, P.; Arunakaran, J. Effects of quercetin on insulin-like growth factors (IGFs) and their binding protein-3 (IGFBP-3) secretion and induction of apoptosis in human prostate cancer cells. J. Carcinog., 2006, 5, 10.
[http://dx.doi.org/10.1186/1477-3163-5-10] [PMID: 16600019]
[18]
Akhtar, S.; Meeran, S.M.; Katiyar, N.; Katiyar, S.K. Grape seed proanthocyanidins inhibit the growth of human non-small cell lung cancer xenografts by targeting insulin-like growth factor binding protein-3, tumor cell proliferation, and angiogenic factors. Clin. Cancer Res., 2009, 15(3), 821-831.
[http://dx.doi.org/10.1158/1078-0432.CCR-08-1901] [PMID: 19188152]
[19]
Harper, C.E.; Cook, L.M.; Patel, B.B.; Wang, J.; Eltoum, I.A.; Arabshahi, A.; Shirai, T.; Lamartiniere, C.A. Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats. Prostate, 2009, 69(15), 1668-1682.
[http://dx.doi.org/10.1002/pros.21017] [PMID: 19670229]
[20]
Krajcik, R.A.; Borofsky, N.D.; Massardo, S.; Orentreich, N. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Cancer Epidemiol. Biomarkers Prev., 2002, 11(12), 1566-1573.
[PMID: 12496045]
[21]
Key, T.J.; Appleby, P.N.; Reeves, G.K.; Roddam, A.W. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: Pooled individual data analysis of 17 prospective studies. Lancet Oncol., 2010, 11(6), 530-542.
[http://dx.doi.org/10.1016/S1470-2045(10)70095-4] [PMID: 20472501]
[22]
McLaughlin, J.M.; Olivo-Marston, S.; Vitolins, M.Z.; Bittoni, M.; Reeves, K.W.; Degraffinreid, C.R.; Schwartz, S.J.; Clinton, S.K.; Paskett, E.D. Effects of tomato- and soy-rich diets on the IGF-I hormonal network: A crossover study of postmenopausal women at high risk for breast cancer. Cancer Prev. Res. (Phila.), 2011, 4(5), 702-710.
[http://dx.doi.org/10.1158/1940-6207.CAPR-10-0329] [PMID: 21430071]
[23]
Teas, J.; Irhimeh, M.R.; Druker, S.; Hurley, T.G.; Hébert, J.R.; Savarese, T.M.; Kurzer, M.S. Serum IGF-1 concentrations change with soy and seaweed supplements in healthy postmenopausal American women. Nutr. Cancer, 2011, 63(5), 743-748.
[http://dx.doi.org/10.1080/01635581.2011.579383] [PMID: 21711174]
[24]
Borenstein, M.; Hedges, L.V.; Higgins, J.P.; Rothstein, H.R. Introduction to meta-analysis, 1st; John Wiley & Sons: Ltd., 2009.
[http://dx.doi.org/10.1002/9780470743386]
[25]
Campbell, M.J.; Woodside, J.V.; Honour, J.W.; Morton, M.S.; Leathem, A.J. Effect of red clover-derived isoflavone supplementation on insulin-like growth factor, lipid and antioxidant status in healthy female volunteers: A pilot study. Eur. J. Clin. Nutr., 2004, 58(1), 173-179.
[http://dx.doi.org/10.1038/sj.ejcn.1601764] [PMID: 14679383]
[26]
Maskarinec, G.; Ju, D.; Morimoto, Y.; Franke, A.A.; Stanczyk, F.Z. Soy food intake and biomarkers of breast cancer risk: Possible difference in Asian women? Nutr. Cancer, 2017, 69(1), 146-153.
[http://dx.doi.org/10.1080/01635581.2017.1250924] [PMID: 27918846]
[27]
Samavat, H.; Wu, A.H.; Ursin, G.; Torkelson, C.J.; Wang, R.; Yu, M.C.; Yee, D.; Kurzer, M.S.; Yuan, J.M. Green tea catechin extract supplementation does not influence circulating sex hormones and insulin-like growth factor axis proteins in a randomized controlled trial of postmenopausal women at high risk of breast cancer. J. Nutr., 2019, 149(4), 619-627.
[http://dx.doi.org/10.1093/jn/nxy316] [PMID: 30926986]
[28]
Wu, A.H.; Yu, M.C.; Tseng, C.C.; Pike, M.C. Epidemiology of soy exposures and breast cancer risk. Br. J. Cancer, 2008, 98(1), 9-14.
[http://dx.doi.org/10.1038/sj.bjc.6604145] [PMID: 18182974]
[29]
Liu, H.S.; Chen, Y.H.; Hung, P.F.; Kao, Y.H. Inhibitory effect of green tea (-)-epigallocatechin gallate on resistin gene expression in 3T3-L1 adipocytes depends on the ERK pathway. Am. J. Physiol. Endocrinol. Metab., 2006, 290(2), E273-E281.
[http://dx.doi.org/10.1152/ajpendo.00325.2005] [PMID: 16159906]
[30]
Li, M.; He, Z.; Ermakova, S.; Zheng, D.; Tang, F.; Cho, Y.Y.; Zhu, F.; Ma, W.Y.; Sham, Y.; Rogozin, E.A.; Bode, A.M.; Cao, Y.; Dong, Z. Direct inhibition of insulin-like growth factor-I receptor kinase activity by (-)-epigallocatechin-3-gallate regulates cell transformation. Cancer Epidemiol. Biomarkers Prev., 2007, 16(3), 598-605.
[http://dx.doi.org/10.1158/1055-9965.EPI-06-0892] [PMID: 17372258]
[31]
Vrieling, A.; Rookus, M.A.; Kampman, E.; Bonfrer, J.M.; Bosma, A.; Cats, A.; van Doorn, J.; Korse, C.M.; Witteman, B.J.; van Leeuwen, F.E.; van’t Veer, L.J.; Voskuil, D.W. No effect of red clover-derived isoflavone intervention on the insulin-like growth factor system in women at increased risk of colorectal cancer. Cancer Epidemiol. Biomarkers Prev., 2008, 17(10), 2585-2593.
[http://dx.doi.org/10.1158/1055-9965.EPI-08-0329] [PMID: 18842999]
[32]
Goodman, M.T.; Shvetsov, Y.B.; Wilkens, L.R.; Franke, A.A.; Le Marchand, L.; Kakazu, K.K.; Nomura, A.M.; Henderson, B.E.; Kolonel, L.N. Urinary phytoestrogen excretion and postmenopausal breast cancer risk: The multiethnic cohort study. Cancer Prev. Res. (Phila.), 2009, 2(10), 887-894.
[http://dx.doi.org/10.1158/1940-6207.CAPR-09-0039] [PMID: 19789300]
[33]
Takata, Y.; Maskarinec, G.; Rinaldi, S.; Kaaks, R.; Nagata, C. Serum insulin-like growth factor-I levels among women in Hawaii and Japan with different levels of tofu intake. Nutr. Cancer, 2006, 56(2), 136-142.
[http://dx.doi.org/10.1207/s15327914nc5602_3] [PMID: 17474858]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy